MEDICAMEQ.NSE Medicamen Biotech Ltd.

Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Medicamen Biotech Ltd. market cap is 6.32B.

52 week high is the highest price of a stock in the past 52 weeks, or one year. Medicamen Biotech Ltd. 52 week high is 845.00 as of May 10, 2024.

52 week low is the lowest price of a stock in the past 52 weeks, or one year. Medicamen Biotech Ltd. 52 week low is 355.45 as of May 10, 2024.

Medicamen Biotech Ltd. stock price today is 512.00.

Medicamen Biotech Ltd. stock price yesterday was 495.00.

The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Medicamen Biotech Ltd.’s P/E ratio is 54.46.

The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Medicamen Biotech Ltd. P/B ratio is 3.1634.

EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Medicamen Biotech Ltd.'s EBITDA is 36.84.

The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Medicamen Biotech Ltd. 50-day moving average is 447.42.

Medicamen Biotech Ltd. has 388 employees.